NCT04831242 Monitoring Key Activity and Physiology of Neonates in Intensive Care
| NCT ID | NCT04831242 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cambridge University Hospitals NHS Foundation Trust |
| Condition | Neonatal Seizure |
| Study Type | OBSERVATIONAL |
| Enrollment | 48 participants |
| Start Date | 2021-08-01 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 48 participants in total. It began in 2021-08-01 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To optimise and evaluate a novel non-contact physiological monitoring system in the neonatal intensive care unit (NICU)
Eligibility Criteria
Inclusion Criteria: * written informed parental consent Exclusion Criteria: \-
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04831242 clinical trial?
This trial is open to participants of all sexes, studying Neonatal Seizure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04831242 currently recruiting?
Yes, NCT04831242 is actively recruiting participants. Contact the research team at kb274@cam.ac.uk for enrollment information.
Where is the NCT04831242 trial being conducted?
This trial is being conducted at Cambridge, United Kingdom.
Who is sponsoring the NCT04831242 clinical trial?
NCT04831242 is sponsored by Cambridge University Hospitals NHS Foundation Trust. The trial plans to enroll 48 participants.